CURE

CNQ:CURE

Biocure Technology Inc.

  • Stock

CAD

Last Close

0.02

11/09 13:30

Market Cap

1.22M

Beta: 2.30

PE Ratio

0.64

PFCF: −3.18

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '14
Mar '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
36.74K
-
-83.54K
327.38%
-2.02M
2,315.18%
-4.78M
136.78%
-6.59M
37.86%
-4.79M
27.26%
-3.08M
35.75%
-1.15M
62.72%
-403.40K
64.85%
-1.47M
263.69%
depreciation and amortization
11.71K
-
28.19K
140.68%
51.88K
84.07%
44.81K
13.63%
54.90K
22.50%
76.88K
40.04%
deferred income tax
97.74K
-
-120.88K
-
-3.16M
2,512.77%
stock based compensation
3.24M
-
1.58M
51.37%
109.25K
93.08%
1.16M
966.29%
change in working capital
54.24K
-
46.72K
13.86%
-196.56K
520.73%
-90.70K
53.86%
575.02K
734.00%
390.40K
32.11%
1.80M
361.89%
1.72M
4.87%
501.44K
70.77%
253.35K
49.48%
accounts receivables
18.06K
-
-537
102.97%
-57.89K
-
20.35K
135.15%
-5.70K
128.00%
-11.39K
99.84%
15.42K
235.42%
inventory
-29.85K
-
10.65K
135.69%
7.58K
28.84%
7.30K
3.75%
41
99.44%
accounts payables
-235.35K
-
437.16K
-
1.79M
309.76%
301.39K
83.18%
452.83K
50.25%
other working capital
36.18K
-
47.26K
30.61%
38.79K
17.92%
-60.85K
256.89%
564.36K
1,027.47%
3.55K
99.37%
-15.69K
541.60%
1.42M
9,148.99%
60K
95.77%
237.93K
296.54%
other non cash items
-122.50K
-
900.35K
-
2.96M
228.99%
28.09K
99.05%
94.37K
236.00%
-78.35K
183.02%
265.34K
438.66%
-916.41K
445.37%
981.25K
207.07%
net cash provided by operating activities
-31.52K
-
-36.82K
16.82%
-1.30M
3,436.32%
-1.88M
44.21%
-2.59M
37.87%
-2.68M
3.64%
-1.31M
51.17%
-1.08M
17.32%
-818.38K
24.46%
-217.13K
73.47%
investments in property plant and equipment
-86.55K
-
-409.10K
372.68%
-938.80K
129.48%
-1.05M
11.80%
-2.86K
99.73%
-3.94K
37.57%
acquisitions net
1.76M
-
purchases of investments
sales maturities of investments
other investing activites
-34.35K
-
-21.84K
36.43%
-34.15K
56.36%
-1.76M
5,048.46%
94.35K
105.37%
74.80K
-
43.31K
42.10%
net cash used for investing activites
-120.90K
-
-430.94K
256.43%
-972.95K
125.77%
-1.05M
7.88%
91.49K
108.72%
-3.94K
104.30%
74.80K
2,000.36%
43.31K
42.10%
debt repayment
-3.59K
-
-568.85K
-
-19K
96.66%
-1.93M
-
-253.00K
86.92%
-102.02K
59.67%
-47K
-
common stock issued
2.87M
-
2.67M
6.88%
1.76M
-
985.38K
43.96%
1.10M
11.44%
common stock repurchased
dividends paid
other financing activites
34.59K
-
35.90K
3.78%
4.37K
-
2.60M
59,557.59%
3.87M
48.54%
401.58K
89.62%
172.55K
57.03%
630.93K
265.65%
187.38K
70.30%
net cash used provided by financing activities
31K
-
35.90K
15.81%
2.30M
6,295.97%
2.65M
15.55%
2.60M
1.85%
3.69M
41.79%
1.13M
69.29%
1.17M
3.06%
630.93K
46.01%
140.38K
77.75%
effect of forex changes on cash
-22.73K
-
-119.71K
426.58%
-16.84K
85.94%
64.53K
483.31%
-1.01K
101.56%
31.00K
3,172.05%
-7.16K
123.11%
net change in cash
-521
-
-924
77.35%
850.30K
92,124.24%
224.66K
73.58%
-974.73K
533.87%
23.82K
102.44%
-85.76K
459.99%
112.42K
231.08%
-119.81K
206.57%
-33.44K
72.09%
cash at beginning of period
2.18K
-
1.66K
23.89%
8.38K
404.94%
858.69K
10,144.40%
1.08M
26.16%
108.62K
89.97%
132.44K
21.93%
46.68K
64.75%
157.48K
237.37%
37.67K
76.08%
cash at end of period
1.66K
-
736
55.66%
858.69K
116,569.29%
1.08M
26.16%
108.62K
89.97%
132.44K
21.93%
46.68K
64.75%
159.10K
240.83%
37.67K
76.32%
4.24K
88.76%
operating cash flow
-31.52K
-
-36.82K
16.82%
-1.30M
3,436.32%
-1.88M
44.21%
-2.59M
37.87%
-2.68M
3.64%
-1.31M
51.17%
-1.08M
17.32%
-818.38K
24.46%
-217.13K
73.47%
capital expenditure
-86.55K
-
-409.10K
372.68%
-938.80K
129.48%
-1.05M
11.80%
-2.86K
99.73%
-3.94K
37.57%
free cash flow
-31.52K
-
-36.82K
16.82%
-1.39M
3,671.35%
-2.29M
64.68%
-3.53M
54.25%
-3.73M
5.82%
-1.31M
64.83%
-1.09M
17.20%
-818.38K
24.73%
-217.13K
73.47%

All numbers in CAD (except ratios and percentages)